help button home button Endocrine Society Endocrinology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Sekine, N.
Right arrow Articles by Fujita, T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Sekine, N.
Right arrow Articles by Fujita, T.
Right arrowPubmed/NCBI databases
*Compound via MeSH
*Substance via MeSH
Hazardous Substances DB
*GLUCOSE
*L-TYROSINE
*NITRIC OXIDE
Endocrinology Vol. 142, No. 9 3909-3916
Copyright © 2001 by The Endocrine Society


ARTICLES

GH Inhibits Interferon-{gamma}-Induced Signal Transducer and Activator of Transcription-1 Activation and Expression of the Inducible Isoform of Nitric Oxide Synthase in INS-1 Cells

Nobuo Sekine, Seiji Fukumoto, Toshio Ishikawa, Tomoki Okazaki and Toshiro Fujita

Department of Internal Medicine, University of Tokyo School of Medicine, Tokyo 113-0033, Japan

Address all correspondence and requests for reprints to: Dr. Nobuo Sekine, Department of Internal Medicine, University of Tokyo School of Medicine, 7-3-1 Hongo, Bunkyo-ku, Tokyo 113-0033, Japan. E-mail: nobuosek-tky{at}umin.ac.jp

Interferon-{gamma} and TNF{alpha} synergistically induce the inducible isoform of nitric oxide synthase and elicit severe cytotoxicity in pancreatic ß-cells. We demonstrate here that GH, the well known ß-cell mitogen, inhibits nitric oxide production by reducing inducible nitric oxide synthase gene induction by the two cytokines and counteracts their cytotoxic effect in insulin-secreting INS-1 cells. To elucidate the underlying mechanism, we examined activation of the transcription factors implicated in the induction of inducible nitric oxide synthase, signal transducer and activator of transcription-1, and nuclear factor-{kappa}B. GH inhibited tyrosine phosphorylation and DNA binding of signal transducer and activator of transcription-1 promoted by interferon-{gamma}, whereas nuclear factor-{kappa}B activation by TNF{alpha} was not affected by GH. GH was found to induce suppressor of cytokine signaling-1 and -3, both of which are able to inhibit interferon-{gamma} activation of signal transducer and activator of transcription-1, suggesting that they are likely to mediate the inhibitory action of GH. Finally, exposure of INS-1 cells to interferon-{gamma} resulted in the impairment of insulin secretion in response to glucose, which was restored by the addition of GH. These results indicate that GH counteracts the effect of interferon-{gamma} through the inhibition of signal transducer and activator of transcription-1. This action of GH may be sufficient to suppress the synergistic induction of inducible nitric oxide synthase by interferon-{gamma} and TNF{alpha}, thereby preventing the cytotoxicity to ß-cells.




This article has been cited by other articles:


Home page
Eur Respir JHome page
C. Grasemann, F. Ratjen, D. Schnabel, E. Reutershahn, U. Vester, and H. Grasemann
Effect of growth hormone therapy on nitric oxide formation in cystic fibrosis patients
Eur. Respir. J., April 1, 2008; 31(4): 815 - 821.
[Abstract] [Full Text] [PDF]


Home page
J EndocrinolHome page
J. Jensen, E. D Galsgaard, A. E Karlsen, Y. C Lee, and J. H Nielsen
STAT5 activation by human GH protects insulin-producing cells against interleukin-1{beta}, interferon-{gamma} and tumour necrosis factor-{alpha}-induced apoptosis independent of nitric oxide production
J. Endocrinol., October 1, 2005; 187(1): 25 - 36.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
T. C. Brelje, L. E. Stout, N. V. Bhagroo, and R. L. Sorenson
Distinctive Roles for Prolactin and Growth Hormone in the Activation of Signal Transducer and Activator of Transcription 5 in Pancreatic Islets of Langerhans
Endocrinology, September 1, 2004; 145(9): 4162 - 4175.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Pathol.Home page
Y. Chen, M. M.W. Chong, R. Darwiche, H. E. Thomas, and T. W.H. Kay
Severe Pancreatitis with Exocrine Destruction and Increased Islet Neogenesis in Mice with Suppressor of Cytokine Signaling-1 Deficiency
Am. J. Pathol., September 1, 2004; 165(3): 913 - 921.
[Abstract] [Full Text] [PDF]


Home page
Mol. Endocrinol.Home page
S. G. Ronn, J. A. Hansen, K. Lindberg, A. E. Karlsen, and N. Billestrup
The Effect of Suppressor of Cytokine Signaling 3 on GH Signaling in {beta}-Cells
Mol. Endocrinol., September 1, 2002; 16(9): 2124 - 2134.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 2001 by The Endocrine Society